Versigent (NYSE:VGNT) Director Kevin Clark Sells 48,592 Shares

Versigent (NYSE:VGNT) Director Kevin Clark sold 48,592 shares of the company’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $48.02, for a total transaction of $2,333,387.84. Following the completion of the sale, the director directly owned 198,979 shares in the company, valued at $9,554,971.58. This trade represents a 19.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Versigent Price Performance

Shares of Versigent stock opened at $46.45 on Friday. The stock has a market capitalization of $3.29 billion and a PE ratio of 24.19. The business’s fifty day simple moving average is $44.28. Versigent has a 1 year low of $26.34 and a 1 year high of $50.88. The company has a current ratio of 1.40, a quick ratio of 1.09 and a debt-to-equity ratio of 7.29.

Versigent (NYSE:VGNT) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $1.92 EPS for the quarter, beating the consensus estimate of $1.58 by $0.34. The business had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.29 billion. As a group, equities analysts expect that Versigent will post 7.23 EPS for the current year.

Versigent Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 18th. Stockholders of record on Friday, September 4th will be paid a $0.13 dividend. The ex-dividend date is Friday, September 4th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.1%.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in VGNT. Wellington Management Group LLP purchased a new position in shares of Versigent during the 2nd quarter valued at approximately $940,000. Ancora Advisors LLC acquired a new position in Versigent during the second quarter worth $4,197,000. Kintegral Advisory LLC acquired a new position in Versigent during the second quarter worth $224,000. Nan Shan Life Insurance Co. Ltd. purchased a new position in Versigent during the second quarter valued at $5,400,000. Finally, Raiffeisen Bank International AG purchased a new position in Versigent during the second quarter valued at $1,182,000.

Analyst Ratings Changes

A number of brokerages have issued reports on VGNT. The Goldman Sachs Group reissued a “buy” rating and issued a $59.00 price target on shares of Versigent in a report on Wednesday, August 5th. Royal Bank Of Canada upgraded shares of Versigent from a “sector perform” rating to an “outperform” rating and boosted their target price for the company from $41.00 to $52.00 in a research note on Wednesday, August 5th. UBS Group dropped their price target on shares of Versigent from $58.00 to $55.00 and set a “buy” rating on the stock in a research report on Thursday, July 9th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $54.00 price objective on shares of Versigent in a report on Wednesday, August 5th. Finally, Evercore reissued an “outperform” rating and set a $65.00 target price on shares of Versigent in a research note on Monday, August 10th. Eleven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $54.00.

About Versigent

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.